Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening (Q27025805)

Deana Manassaram-Baptiste

2

1 reference

Durado Brooks

3

1 reference

Vilma Cokkinides

4

1 reference

Mary Doroshenk

5

1 reference

Debbie Saslow

6

1 reference

Richard C. Wender

7

1 reference

Otis W. Brawley

8

1 reference

language of work or name

1 reference

2014

1 reference

1 reference

64

1 reference

PubMed

page(s)

30-51

1 reference

PubMed

issue

1

1 reference

New American Cancer Society process for creating trustworthy cancer screening guidelines.

PubMed

cites work

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Cancer screening in the United States, 2012: A review of current American Cancer Society guidelines and current issues in cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

American Cancer Society guidelines for breast cancer screening: update 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

American Cancer Society guideline for the early detection of cervical neoplasia and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

American Cancer Society guideline for the early detection of prostate cancer: update 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

American Cancer Society lung cancer screening guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Breast cancer incidence rates in U.S. women are no longer declining

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Perceived cancer risk: why is it lower among nonwhites than whites?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Cancer screening in elderly patients: a framework for individualized decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

A breast cancer prediction model incorporating familial and personal risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Which risk model to use? Clinical implications of the ACS MRI screening guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Mammographic features and breast cancer risk: effects with time, age, and menopause status.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Digital breast tomosynthesis: the future of mammography screening or much ado about nothing?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Improved breast cancer detection in asymptomatic women using 3D-automated breast ultrasound in mammographically dense breasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Long-term colorectal-cancer incidence and mortality after lower endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Long-term mortality after screening for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Informed decision making changes test preferences for colorectal cancer screening in a diverse population

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Screening for prostate cancer in U.S. men ACPM position statement on preventive practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

American Urological Association (AUA) guideline on prostate cancer detection: process and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Early detection of prostate cancer: AUA Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

National evidence on the use of shared decision making in prostate-specific antigen screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Pairing physician education with patient activation to improve shared decisions in prostate cancer screening: a cluster randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Mortality results from a randomized prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Radical prostatectomy versus observation for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Early Lung Cancer Action Project: overall design and findings from baseline screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Reduced lung-cancer mortality with low-dose computed tomographic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Benefits and harms of CT screening for lung cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

The role of CA125 in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Tumor markers for early detection of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Biomarkers for screening, diagnosis, and monitoring of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Effect of Screening on Ovarian Cancer Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Priorities among effective clinical preventive services: results of a systematic review and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Delivery of cancer screening: how important is the preventive health examination?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

A perspective from countries using organized screening programs

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Existing Medicaid beneficiaries left off the Affordable Care Act's prevention bandwagon

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

Prostate Cancer Screening Decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21212

21 January 2018

Identifiers

DOI

10.3322/CAAC.21212

1 reference

Consolidated OpenCitations Corpus – April 2017

1942350

1942350

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference